Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome
- 30 November 1987
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 111 (5) , 740-743
- https://doi.org/10.1016/s0022-3476(87)80258-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effect of Oral Glucose Administration on Plasma Growth Hormone-Releasing Hormone (GHRH)-Like Immunoreactivity Levels in Normal Subjects and Patients with Idiopathic GH Deficiency: Evidence that GHRH Is Released Not Only from the Hypothalamus but Also from Extrahypothalamic Tissue*Journal of Clinical Endocrinology & Metabolism, 1987
- The Response of Serum Growth Hormone Levels to the Long-Acting Somatostatin Analog SMS 201-995 in AcromegalyJournal of Clinical Endocrinology & Metabolism, 1987
- McCune-Albright SyndromePublished by American Medical Association (AMA) ,1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Gigantism Associated with McCune-Albright's SyndromeHormone and Metabolic Research, 1985
- Acromegaly and Hyperprolactinemia in McCune-Albright SyndromeAmerican Journal of Diseases of Children, 1983
- Treatment of juvenile acromegaly with bromocriptineThe Journal of Pediatrics, 1981
- Pituitary adenoma in McCune-Albright syndrome: Follow-up informationThe Journal of Pediatrics, 1976
- McCune-Albright syndrome associated with a functioning pituitary chromophobe adenomaThe Journal of Pediatrics, 1976
- Effect of Somatostatin in Patients with AcromegalyNew England Journal of Medicine, 1974